{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:32:08Z","timestamp":1786516328043,"version":"build-2736575974"},"reference-count":28,"publisher":"Bentham Science Publishers Ltd.","issue":"3","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82470507"],"award-info":[{"award-number":["82470507"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82070491"],"award-info":[{"award-number":["82070491"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CCR"],"published-print":{"date-parts":[[2026,3]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>Peripheral arterial disease (PAD) is a significant contributor to global\nmorbidity, with regional burdens exhibiting considerable heterogeneity. The PAD burden attributable\nto metabolic risks across regions with varying socioeconomic levels has yet to be adequately\ncharacterized.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>This study analyzes PAD burden attributable to metabolic risks across different socioeconomic\nregions using data from the Global Burden of Disease (GBD) 2021 study. We analyzed\ndata on PAD attributable to metabolic risks, including high systolic blood pressure (SBP),\nhigh fasting plasma glucose (FPG), kidney dysfunction (KD), and high body mass index (BMI),\nacross four health systems, four world bank income levels, five Socio-demographic Index (SDI)\nlevels, and 21 GBD regions, from 1990 to 2021. We presented age-standardized mortality rates\n(ASMR), age-standardized disability-adjusted life year rates (ASDR) and estimated annual percentage\nchanges (EAPC) to assess burden and trends.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>In 2021, the burden of PAD due to metabolic risks remained high in regions with higher\nsocioeconomic levels, though it showed a declining trend. Conversely, the burden in regions with\nlower socioeconomic levels was also high but exhibited an increasing trend. High FPG has become\na significant factor in the burden of PAD, particularly in higher socioeconomic regions. Gender\ndisparities in the burden of PAD attributable to metabolic risks were evident, with males exhibiting\nhigher ASMR and ASDR, although females in middle-income regions had slightly elevated ASDRs.\nFinally, an inverted \"U\" relationship was observed between SDI and burden, with regions\naround an SDI of 0.75 exhibiting a higher burden of PAD attributable to metabolic risks.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion:<\/jats:title>\n                    <jats:p>These findings underscore the urgent need to tailor region-specific public health\nstrategies that account for socioeconomic disparities in metabolic risk exposures contributing to\nthe PAD burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Effective public health interventions targeting these metabolic risks are urgently\nneeded, especially in low-socioeconomic regions where the burden remains disproportionately\nhigh. Enhanced blood glucose control and early intervention strategies should be prioritized to\nmitigate the growing impact of PAD globally.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/011573403x384355250731031837","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T04:40:46Z","timestamp":1754368846000},"update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic Risk-attributable Burden of Peripheral Arterial Disease across Socioeconomic Regions: Insights from the Global Burden of Disease Study 2021"],"prefix":"10.2174","volume":"22","author":[{"given":"Chang","family":"Sheng","sequence":"first","affiliation":[{"name":"Department of General and Vascular Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan,China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Changsha 410008, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of General and Vascular Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan,China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Changsha 410008, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of General and Vascular Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan,China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Changsha 410008, Hunan, China"},{"name":"Clinical Research Center for Vascular Intervention in Hunan Province, XiangyaHospital, Central South University, Changsha 410008, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0957-5762","authenticated-orcid":true,"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of General and Vascular Surgery, Xiangya Hospital, Central South University, Changsha 410008, Hunan,China"},{"name":"National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University,Changsha 410008, Hunan, China"},{"name":"Clinical Research Center for Vascular Intervention in Hunan Province, XiangyaHospital, Central South University, Changsha 410008, Hunan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"e1313","DOI":"10.1161\/CIR.0000000000001251","volume":"149","author":"Gornik H.L.","year":"2024","unstructured":"Gornik H.L.; Aronow H.D.; Goodney P.P.; 2024 ACC\/AHA\/AACVPR\/APMA\/ABC\/SCAI\/SVM\/SVN\/SVS\/SIR\/VESS Guideline for the management of lower extremity peripheral artery disease: A report of the american college of cardiology\/american heart association joint committee on clinical practice guidelines. Circulation  2024,149(24),e1313-e1410","journal-title":"Circulation"},{"key":"ref=2","year":"2024","unstructured":"GBD 2021 Cause and Risk Summary: Lower extremity peripheral arterial disease. Institute for Health Metrics and Evaluation  2024","journal-title":"Institute for Health Metrics and Evaluation"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1016\/j.jvs.2022.12.015","volume":"77","author":"Eid M.A.","year":"2023","unstructured":"Eid M.A.; Mehta K.; Barnes J.A.; The global burden of peripheral artery disease. J Vasc Surg  2023,77(4),1119-1126.e1","journal-title":"J Vasc Surg"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"19898","DOI":"10.1038\/s41598-023-47028-5","volume":"13","author":"You Y.","year":"2023","unstructured":"You Y.; Wang Z.; Yin Z.; Global disease burden and its attributable risk factors of peripheral arterial disease. Sci Rep  2023,13(1),19898","journal-title":"Sci Rep"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"e1553","DOI":"10.1016\/S2214-109X(23)00355-8","volume":"11","author":"Kim M.S.","year":"2023","unstructured":"Kim M.S.; Hwang J.; Yon D.K.; Global burden of peripheral artery disease and its risk factors, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet Glob Health  2023,11(10),e1553-e1565","journal-title":"Lancet Glob Health"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","volume":"41","year":"2018","unstructured":"Economic costs of diabetes in the U.S. in 2017. Diabetes Care  2018,41(5),917-928","journal-title":"Diabetes Care"},{"key":"ref=7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.119.012277","volume":"8","author":"Shahu A.","year":"2019","unstructured":"Shahu A.; Herrin J.; Dhruva S.S.; Disparities in socioeconomic context and association with blood pressure control and cardiovascular outcomes in allhat. J Am Heart Assoc  2019,8(15)","journal-title":"J Am Heart Assoc"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1038\/nrcardio.2016.179","volume":"14","author":"Fowkes F.G.R.","year":"2017","unstructured":"Fowkes F.G.R.; Aboyans V.; Fowkes F.J.I.; McDermott M.M.; Sampson U.K.A.; Criqui M.H.; Peripheral artery disease: Epidemiology and global perspectives. Nat Rev Cardiol  2017,14(3),156-170","journal-title":"Nat Rev Cardiol"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Ferrari A.J.","year":"2024","unstructured":"Ferrari A.J.; Santomauro D.F.; Aali A.; Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet  2024,403(10440),2133-2161","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","volume":"403","author":"Naghavi M.","year":"2024","unstructured":"Naghavi M.; Ong K.L.; Aali A.; Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: A systematic analysis for the global burden of disease study 2021. Lancet  2024,403(10440),2100-2132","journal-title":"Lancet"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","volume":"388","author":"Wang H.","year":"2016","unstructured":"Wang H.; Naghavi M.; Allen C.; Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: A systematic analysis for the Global Burden of Disease Study 2015. Lancet  2016,388(10053),1459-1544","journal-title":"Lancet"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.03.002","volume":"347","author":"Liu W.","year":"2022","unstructured":"Liu W.; Yang C.; Chen Z.; Global death burden and attributable risk factors of peripheral artery disease by age, sex, SDI regions, and countries from 1990 to 2030: Results from the Global Burden of Disease study 2019. Atherosclerosis  2022,347,17-27","journal-title":"Atherosclerosis"},{"key":"ref=13","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2024.155958","volume":"158","author":"Danpanichkul P.","year":"2024","unstructured":"Danpanichkul P.; Suparan K.; Dutta P.; Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: A systematic analysis from the global burden of disease study 2019. Metabolism  2024,158","journal-title":"Metabolism"},{"key":"ref=14","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2024.103025","volume":"18","author":"Dong X.J.","year":"2024","unstructured":"Dong X.J.; Zhang X.Q.; Wang B.B.; Hou F.F.; Jiao Y.; The burden of cardiovascular disease attributable to high fasting plasma glucose: Findings from the global burden of disease study 2019. Diabetes Metab Syndr  2024,18(5)","journal-title":"Diabetes Metab Syndr"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1093\/eurjpc\/zwae040","volume":"31","author":"Khan Minhas A.M.","year":"2024","unstructured":"Khan Minhas A.M.; Sedhom R.; Jean E.D.; Global burden of cardiovascular disease attributable to smoking, 1990\u20132019: An analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol  2024,31(9),1123-1131","journal-title":"Eur J Prev Cardiol"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"Fowkes F.G.R.","year":"2013","unstructured":"Fowkes F.G.R.; Rudan D.; Rudan I.; Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: A systematic review and analysis. Lancet  2013,382(9901),1329-1340","journal-title":"Lancet"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","volume":"396","author":"Vos T.","year":"2020","unstructured":"Vos T.; Lim S.S.; Abbafati C.; Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: A systematic analysis for the Global Burden of Disease Study 2019. Lancet  2020,396(10258),1204-1222","journal-title":"Lancet"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.2337\/diacare.24.8.1433","volume":"24","author":"Jude E.B.","year":"2001","unstructured":"Jude E.B.; Oyibo S.O.; Chalmers N.; Boulton A.J.M.; Peripheral arterial disease in diabetic and nondiabetic patients: A comparison of severity and outcome. Diabetes Care  2001,24(8),1433-1437","journal-title":"Diabetes Care"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","volume":"41","author":"Cosentino F.","year":"2020","unstructured":"Cosentino F.; Grant P.J.; Aboyans V.; 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J  2020,41(2),255-323","journal-title":"Eur Heart J"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"e722","DOI":"10.1161\/CIR.0000000000001040","volume":"145","author":"Joseph J.J.","year":"2022","unstructured":"Joseph J.J.; Deedwania P.; Acharya T.; Comprehensive management of cardiovascular risk factors for adults with type 2 diabetes: A scientific statement from the american heart association. Circulation  2022,145(9),e722-e759","journal-title":"Circulation"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1161\/CIRCULATIONAHA.107.725101","volume":"116","author":"Hirsch A.T.","year":"2007","unstructured":"Hirsch A.T.; Murphy T.P.; Lovell M.B.; Gaps in public knowledge of peripheral arterial disease: The first national PAD public awareness survey. Circulation  2007,116(18),2086-2094","journal-title":"Circulation"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.amjmed.2019.04.043","volume":"132","author":"Campia U.","year":"2019","unstructured":"Campia U.; Gerhard-Herman M.; Piazza G.; Goldhaber S.Z.; Peripheral artery disease: Past, present, and future. Am J Med  2019,132(10),1133-1141","journal-title":"Am J Med"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1093\/eurheartj\/ehz880","volume":"41","author":"Sundaram V.","year":"2020","unstructured":"Sundaram V.; Bloom C.; Zakeri R.; Temporal trends in the incidence, treatment patterns, and outcomes of coronary artery disease and peripheral artery disease in the UK, 2006\u20132015. Eur Heart J  2020,41(17),1636-1649","journal-title":"Eur Heart J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"i3283","DOI":"10.1136\/bmj.i3283","volume":"353","author":"Matthews A.","year":"2016","unstructured":"Matthews A.; Herrett E.; Gasparrini A.; Impact of statin related media coverage on use of statins: Interrupted time series analysis with UK primary care data. BMJ  2016,353,i3283","journal-title":"BMJ"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1016\/S0140-6736(11)61215-4","volume":"378","author":"Yusuf S.","year":"2011","unstructured":"Yusuf S.; Islam S.; Chow C.K.; Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): A prospective epidemiological survey. Lancet  2011,378(9798),1231-1243","journal-title":"Lancet"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.jacc.2008.08.049","volume":"52","author":"Joshi R.","year":"2008","unstructured":"Joshi R.; Jan S.; Wu Y.; MacMahon S.; Global inequalities in access to cardiovascular health care: Our greatest challenge. J Am Coll Cardiol  2008,52(23),1817-1825","journal-title":"J Am Coll Cardiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"Song P.","year":"2019","unstructured":"Song P.; Rudan D.; Zhu Y.; Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: An updated systematic review and analysis. Lancet Glob Health  2019,7(8),e1020-e1030","journal-title":"Lancet Glob Health"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1177\/1358863X10378376","volume":"15","author":"Xu D.","year":"2010","unstructured":"Xu D.; Li J.; Zou L.; Sensitivity and specificity of the ankle\u2014brachial index to diagnose peripheral artery disease: A structured review. Vasc Med  2010,15(5),361-369","journal-title":"Vasc Med"}],"container-title":["Current Cardiology Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011573403X384355250731031837","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/244154\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/011573403X384355250731031837","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T06:02:22Z","timestamp":1786514542000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/244154\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/011573403x384355250731031837","relation":{},"ISSN":["1573-403X"],"issn-type":[{"value":"1573-403X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2025-02-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-24","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e1573403X384355"}}